New COVID-19 Vaccine Codes: November Update (November Special Update 2022)

Why This Topic Matters

Keeping pace with vaccine coding updates is important for accurate reporting, compliance, and alignment with current CPT guidance. This article helps readers understand what changed in the CPT vaccine coding structure and where the new information fits within Appendix Q and related immunization administration guidance.

Article Sections

1. November Special Update 2022 page 1

   Introduces the November 2022 CPT vaccine coding update and the broader context for the changes discussed in the article.

2. Immunization Administration for Vaccines/Toxoids

   Summarizes the new administration code and its relationship to the updated COVID-19 vaccine product coding.

3. Vaccines, Toxoids

   Summarizes the new vaccine product code and the related reporting context within the vaccine code category.

4. Table 1 Excerpt from Appendix Q: New Moderna Bivalent Booster COVID-19 Vaccine Product and Vaccine Administration Codes

   Presents an Appendix Q excerpt showing the new vaccine product and administration pairing along with the applicable patient age range.

5. Clinical Example (91316) / Description of Procedure (91316)

   Provides a clinical scenario and procedural context associated with the new vaccine product code.

6. Clinical Example (0164A) / Description of Procedure (0164A)

   Provides a clinical scenario and procedural context associated with the new administration code.